乳腺癌SPECT分子显像靶点基础研究进展

doi:10.11904/j.issn.1002-3070.2016.03.016

Abstract

Abstract: The technique of molecular imaging of breast cancer has made great advances in recent years,more and more specific targets were found.This article compares several successful breast cancer targets of molecular imaging with SPECT,such as MDM2,γH2AX,Annexin V and HER-2 etc.This paper reviews the research status of these targets and imaging techniques to lay the foundation for further progress of molecular imaging for breast cancer with SPECT.

Key words: Breast cancer, SPECT, MDM2, γH2AX, Annexin V

CLC Number:

R737.9

WANG Xinyu,KAN Qingpeng,ZHAO Changjiu. Advanced basic research on breast cancer targets of molecular imaging with SPECT[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(3): 271-274.

References

1 Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[J].Cell,2011,144(5):646-674.
2 李亚明.进入多模态、分子显像新时代的核医学[J].山西医科大学学报,2014,45(3):165-166.
3 中华医学会核医学分会.乳腺核医学检查共识[J].中华放射学杂志,2014,48(9):726-729.
4 Fu P,Shen B,Zhao C,et al.Molecular imaging of MDM2 messenger RNA with ^99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts[J].J Nucl Med,2010,51(11):1805-1812.
5 Cornelissen B,Kersemans V,Darbar S,et al.Imaging DNA damage in vivo using H2AX-targeted immunoconjugates[J].Cancer Research,2011,71(13):4539-4549.
6 罗瑞,王峰,侯彦杰,等.99Tcm-TP5-3 microSPECT/CT探测乳腺癌化疗后细胞凋亡的实验研究[J].中华核医学与分子影像杂志,2014,34(4):312-316.
7 Vallis KA,Reilly RM,Scollard D,et al.Phase I trial to evaluate the tumor and normal tissue uptake,radiation dosimetry and safety of(111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer[J].Am J Nucl Med Mol Imaging,2014,4(2):181-192.
8 Ahlgren S,Orlova A,Wallberg H,et al.Targeting of HER2-expressing tumors using ¹¹¹In-ABY-025,a second-generation affibody molecule with a fundamentally reengineered scaffold[J].J Nucl Med,2010,51(7):1131-1138.
9 Li H,Liu Q,Wang Z,et al.The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast Cancer[J].J Bio Chem,2015,290(37):22649-22661.
10 Senturk E,Manfredi JJ.Mdm2 and tumorigenesis:evolving theories and unsolved mysteries[J].Genes Cancer,2012,3(3-4):192-198.
11 Chen X,Qiu J,Yang D,et al.MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9[J].PLoS One,2013,8(11):e78794.
12 Qin JJ,Nag S,Voruganti S,et al.Natural product MDM2 inhibitors:anticancer activity and mechanisms of action[J].Curr Med Chem,2012,19(33):5705-5725.
13 Sepideh S,Mohammadreza JN,Ali D,et al.Study of the Murine Double Minute 2 status in patients with gastric and colorectal carcinomas and its correlation with prognostic factors[J].Indian J Pathol Microbiol,2012,55(2):192-195.
14 Rayburn ER,Ezell SJ,Zhang R.Recent advances in validating MDM2 as a cancer target[J].Anticancer Agents Med Chem,2009,9(8):882-903.
15 Park HS,Park JM,Park S,et al.Subcellular localization of Mdm2 expression and prognosis of breast cancer[J].Int J Clin Oncol,2014,19(5):842-851.
16 Fu P,Sun L,Cao X.MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft[J].Mol Imaging,2014,13(2):1-10.
17 曾群力.γH2AX[J].中华预防医学杂志,2006,3(40):158.
18 Ciccia A,Elledge SJ.The DNA damage response:making it safe to play with knives[J].Molecular Cell,2010,40(2):179-204.
19 Bartek J,Lukas J,Bartkova J.DNA damage response as an anti-cancer barrier:damage threshold and the concept of ′conditional haploinsufficiency′[J].Cell Cycle,2007,6(19):2344-2347.
20 崔铭,刘杨,王光熙,等.DNA损伤标志物γH2AX及其在临床肿瘤研究中的应用[J].中华病理学杂志,2014,43(10):714-717.
21 Bhatia A,Dey P,Goel S,et al.Expression of gammaH2AX may help in defining a genetically more stable subtype of infiltrating ductal carcinoma of breast[J].Indian J Med Res,2013,137(4):759-766.
22 Cornelissen B,Kersemans V,Darbar S,et al.Imaging DNA damage in vivo using gamma H2AX-targeted immunoconjugates[J].Cancer Research,2011,71(13):4539-4549.
23 Schaper FL,Reutelingsperger CP.^99mTc-HYNIC-Annexin A5 in oncology:evaluating efficacy of anti-cancer therapies[J].Cancers,2013,5(2):550-568.
24 Deng S,Wang J,Hou L,et al.Annexin A1,A2,A4 and A5 play important roles in breast cancer,pancreatic cancer and laryngeal carcinoma,alone and/or synergistically[J].Oncol Lett,2013,5(1):107-112.
25 Siena S,Sartore-Bianchi A,Di Nicolantonio F,et al.Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer[J].J Nati Cancer Inst,2009,101(19):1308-1324.
26 Silva AR.Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation[J].Int J Surg Pathol,2006,14(3):268-269.
27 邓再兴,俞文菊,朱凯.乳腺癌组织CK5/6与EGFR表达及其临床意义的研究[J].中华肿瘤防治杂志,2008,15(19):1477-1480.
28 孙刚,杨乐,董朝,等.不同亚型乳腺癌组织中EGFR、PI3 K及其磷酸化表达差异和特征分析[J].中华内分泌外科杂志,2014,3(8):207-212.
29 王荣荣,刘晓,陆苏,等.乳腺癌中BAG-1 EGFR和PARP-1的表达及其临床意义[J].中国肿瘤临床,2014,41(13):866-871.
30 Reilly RM,Chen P,Wang J,et al.Preclinical pharmacokinetic,biodistribution,toxicology,and dosimetry studies of ¹¹¹In-DTPA-human epidermal growth factor:an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer[J].J Nucl Med,2006,47(6):1023-1031.
31 赵新明,韩静雅,贾立镯.脂质体介导TCm-EG荷SKOV3卵巢癌裸FR mRNA反义肽核酸在鼠体内的分布及显像[J].中华核医学与分子影像杂志,2014,5(34):379-384.
32 李晓琳,谢鹏,孟雪,等.表皮生长因子受体分子显像与基因突变在非小细胞肺癌中的研究进展[J].中华核医学与分子影像杂志,2012,32(5):393-396.
33 刘秋雨,孔令非,刘正国.乳腺癌HER-2基因检测的临床价值[J].中华实用诊断与治疗杂志,2010,24(8):778-780.
34 李欣,蔡炯.HER-2放射性配体Tcm-ABH2的制备及荷乳腺癌裸鼠显像[J].中华核医学与分子影像杂志,2015,3(35):222-226.
35 Sorensen J,Sandberg D,Sandstrom M,et al.First-in-human molecular imaging of HER-2 expression in breast cancer metastases using the ¹¹¹In-ABY-025 affibody molecule[J].J Nucl Med,2014,55(5):730-735.
36 Razumienko E,Dryden L,Scollard D,et al.MicroSPECT/CT imaging of co-expressed HER-2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates[J].Breast Cancer Res Treat,2013,138(3):709-718.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	LI Shuo,ZHANG Nannan,LI Liangliang,LONG Zhiping,YIN Huihui,ZHAO Yashuang,WANG Fan. Relationship between PDE4C gene methylation in peripheral blood leukocytes,interaction of environmental factors and pathogenesis of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 233-238.
[3]	CHEN Yanbo, KONG Dejia, ZHANG Jinfeng, MA Zhigang. Correlation between CYP2D6 gene polymorphism and tamoxifen metabolism in breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 110-114.
[4]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.
[5]	MA Zhijie, WANG Fan, ZHAO Yashuang. Analysis of life quality and influencing factors in breast cancer patients with chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 149-154.
[6]	MA Zhingying, SHANG Naijian, CAI Miaotian, SHEN Yang, JIANG Zhiyun. Correlation between HER-2 receptor of progesterone and estrogen receptor-positive breast cancer and mammography imaging & clinicopathological features [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 47-51.
[7]	SHI Jun, NI Xiaobing, MAO Min, PENG Xingchun. Inhibitory effect and mechanism of Nultin-3 combined with cisplatin on oral squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 488-492.
[8]	HE Xu, YE shangmian, DONG dandan, LI Ke. The expression of HLA-G in breast cancer and its significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 410-414.
[9]	LIN Rongjie, YIN Hang, ZHOU Yunfeng. Effect of ON123300 on ER+ human breast cancer MCF-7 cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 193-197.
[10]	LI Lin, LI Zhigao. The relationship between metformin and different molecular subtypes of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 267-270.
[11]	ZHENG Wei, XU Shouping, PANG Da. Expression,prognosis and function of long chain non-coding RNA-Linc00152 in breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 7-13.
[12]	YIN Yulian, ZHANG Weihong, ZHOU Yue, YE Meina, CHEN Hongfeng. Correlation between single nucleotide polymorphisms of ERα gene and bone loss associated with aromatase inhibitors in postmenopausal women with breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 14-18.
[13]	LI Yujiao, SHANG Naijian. Research progress of imaging evaluation of neoadjuvant chemotherapy in breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 63-67.
[14]	ZHAO Qianyu, SUN Yihua. Progress of Raman spectroscopy in cancer diagnosis of human organization [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 92-96.
[15]	CHEN Zhuo, KONG Yiran. Effect of silencing UHRF1 on proliferation and metastasis of breast cancer cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 512-518.

Advanced basic research on breast cancer targets of molecular imaging with SPECT

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments